companydata.dkNordre Fasanvej 216 Komplementarselskab ApS: Financial statements 2025
CVR: 41236078
Nordre Fasanvej 216 Komplementarselskab ApS (CVR 41236078) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 875 and a net result of DKK 1,226 compared with DKK 752 the year before. That is an increase of 250% compared with the year before. Equity amounted to DKK 35,058. The solvency ratio was 90.5%.
- Gross Profit
- 875 kr.
- Profit/Loss
- 1,226 kr.
- Equity
- 35,058 kr.
- Total Assets
- 38,730 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 875 | 1 t. | 35 t. | 0 |
| 2024 | - | 250 | 752 | 34 t. | 0 |
| 2023 | 0 | -3 t. | 0 | 33 t. | - |
| 2022 | - | -3 t. | 0 | 33 t. | - |
| 2021 | - | -3 t. | 0 | 33 t. | - |
Find more companies like Nordre Fasanvej 216 Komplementarselskab ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2025
Nordre Fasanvej 216 Komplementarselskab ApS has published its annual report for 2024. Gross profit came to DKK 250, and the net result was DKK 752.
About Nordre Fasanvej 216 Komplementarselskab ApS
Nordre Fasanvej 216 Komplementarselskab ApS is a Danish company of the type Anpartsselskab based in Aarhus C, founded in 2020. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Erik Wihlborg. The company's owners include ARKMEDIC ApS, Lene Agersnap and Morten Haaning Charles. In 2025, the company reported a gross profit of DKK 875 and a net result of DKK 1,226 compared with DKK 752 the year before. Equity amounted to DKK 35,058.